R&D Systems™ Recombinant Human MIF Protein, CF

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Applications: Bioactivity

The Recombinant Human MIF Protein is derived from E. coli. The Recombinant Human MIF Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: AAA36315
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 4282
• Molecular Weight (g/mol): 12.4 kDa & 12.3 kDa
• Quantity: 2 μg
• Source: E. coli-derived human MIF protein Pro2-Ala115,with an N-terminal Met
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after opening. 3 months, -20 to -70 °C under sterile conditions after opening.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Specific Reactivity: MIF
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Buffer: Supplied as a 0.2 μm filtered solution in MES and NaCl.
• Purity or Quality Grade: >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.